TokenPost topic

IBI3001

1 TokenPost story is tagged IBI3001. The newest appear first.

Latest IBI3001 stories

• Innovent's IBI354 Records 95% Response Rate in 20-Patient Breast Cancer Study

  A separate Phase 1 study of IBI3001 found response activity in lung cancer and a 6.9-month median progression-free survival in a listed pancreatic cancer group.

  Oct 26, 2026, 12:08 AM EDT · Business